Table 2

Laboratory investigations of multisystem inflammatory syndrome in children cases across the age categories*†

Total
(n=41)
<5 years
(n=18)
5–12 years
(n=19)
>12–20 years
(n=4)
Hemogram at the time of presentation
 Haemoglobin (Hb) g/L (mean±SD)107.7±16.2103.0±17.3110.9±12.3106.0±27.4
 Total leucocyte count (TLC) 109 /L (mean±SD)11.2±4.812.9±5.410.5±3.57.1±4.6
 Platelets (PLT) 109 /L (mean±SD)248±167303±159220±176131±26
 Anaemia (Hb <110 g/L)—no. (%)20 (49)10 (56)7 (37)3 (75)
 Leucopenia (TLC <4.0 × 109 cells/L)—no. (%)2 (5)1 (6)0 (0)1 (25)
 Thrombocytopenia (PLT<150 × 109 cells/L)—no. (%)13 (31)3 (17)7 (37)3 (75)
 Pancytopenia—no. (%)‡2 (5)1 (6)0 (0)1 (25)
 Lymphopenia—no. (%)§26 (63)7 (39)15 (19)4 (100)
Peak values
 CRP mg/L—mean±SD or median (IQR)119±7986±63145±84146 (64–234)
 Positive CRP (>1 mg/L)41 (100)18 (100)19 (100)4 (100)
 CRP (1-50) mg/L—no. (%)10 (24)7 (39)2 (11)1 (25)
 CRP (51-100) mg/L—no. (%)8 (20)5 (28)3 (16)0 (0)
 CRP (>100) mg/L—no. (%)23 (56)6 (33)14 (73)3 (75)
 Procalcitonin μg/L
 Median (IQR)8.9 (1.6–51.0)11.4 (1.5–54.2)3.7 (1.5–13.8)48 (7.2–53.0)
 no./total no. (%)16/41 (39)8/18 (44)5/19 (26)3/4 (75)
 High procalcitonin (>0.5 µg/L) no./total no. (%)16/16 (100)8/8 (100)5/5 (100)3/3 (100)
 Ferritin μg/L Median (IQR)350 (170–733)189 (98–429)570 (266–961)777 (180–1332)
 High ferritin (>300 µg/L) no./total no. (%)22 (54)7 (39)13 (68)2 (50)
 D-dimer mg/L Median (IQR)2.5 (1.1–4.3)1.5 (0.9–3.3)3.8 (1.5–5.2)2.6 (1.6–4.2)
 High D-dimer (>0.5 mg/L) - no.(%)40 (98)18 (100)18 (94)4 (100)
 Sodium mmol/L Mean±SD135±5135±6135±5137±4
 Hyponatraemia (sodium <135 mmol/L) no.(%)9 (22)3 (17)5 (26)1 (25)
 Albumin g/L (mean±SD)28.6±7.129.5±6.928.3±7.926.5±4.7
 Hypoalbuminaemia (albumin <35 g/L) no.(%)31 (76)14 (78)13 (68)4 (100)
 AST IU/L median (IQR)35.0 (27.0–76.5)28.0 (22.5–47.5)34.0 (23.0–60.0)110.0 (37.0–351.0)
 ALT IU/L median (IQR)29.5 (22.3–51.0)40.0 (27.5–63.5)29.0 (20.0–45.0)89.0 (35.5–442)
 Transaminitis¶ no.(%)19 (46)9 (50)7 (37)3 (75)
 Acute kidney injury (AKI)**4 (10)1 (6)1 (5)2 (50)
 Sterile pyuria— no./total no. (%)10/20 (50)4/10 (40)4/7 (57)2/3 (67)
 Proteinuria— no./total no. (%)6/20 (30)1/10 (10)3/7 (43)2/3 (67)
 Troponin ng/L Median (IQR)
 no./ total no. (%)
16 (6.7–30.0)19 (6.0–41.2)10.2 (4.0–35.6)19.3 (14.5–27.4)
30/41 (73)12/18 (67)14/19 (74)4/4 (100)
 Elevated troponin (>20 ng/L) no./ total no. (%)10/30 (33)6/12 (50)3/14 (21)1/4 (25)
 NT-ProBNP (pg/mL) Median (IQR)
 no./ total no. (%)
1845 (403–6840)4342 (815–7803)529 (248–4647)3530 (2679–4382)
19/41 (46)8/18 (44)9/19 (47)2/4 (50)
 Elevated NT-proBNP (>125 pg/mL) no./ total no. (%)18/19 (95)8/8 (100)8/9 (89)2/2 (100)
 Fibrinogen g/L Mean±SD3.9±1.83.5±0.84.2±2.23.37
 no./total no. (%)11/41 (27)3/18 (17)7/19 (37)1/4 (25)
 Hypofibrinogenaemia (fibrinogen <2.0 g/L) no./ total no. (%)1/11 (9)0/3 (0)1/7 (14)0/1 (0)
 ESR mm/hour Mean±SD33.4±20.735.3±15.941.2±24.47.5±0.7
 no./total no. (%)14/41 (34)7/18 (39)5/19 (26)2/4 (50)
 High ESR (>20) no./total no. (%)10/14 (71)6/7 (86)4/5 (80)0/2 (0)
  • *Percentages may not total 100 because of rounding.

  • †CRP denotes C-reactive protein, AST aspartate aminotransferase, ALT alanine aminotransferase, NT-ProBNP N-terminal pro–B-type natriuretic peptide, ESR Erythrocyte sedimentation rate, IQR denotes interquartile range showing 25th and 75th centiles, and SD is the standard deviation.

  • ‡Pancytopenia defined as hemoglobin <110 g/L, total leukocyte count < 4.0 x 109 /L and platelets < 150 x 109 /L.

  • §Lymphopenia defined as <3000 lymphocytes/μL (<2 years age), <1500 lymphocytes/μL (2-12 years age), and <1000 lymphocytes/μL (>12 years age).

  • ¶Transaminitis defined as AST or ALT >40 IU/L.

  • **Acute Kidney Injury (AKI) is defined as any of the following: increase in serum creatinine by ≥ 0.3mg/dl (≥ 26.5 µmol/l) within 48 hours; or increase in serum creatinine to ≥ 1.5 times baseline, whichis known or presumed to have occurred within the prior 7 days; or urine volume <0.5 ml/kg/h for 6 hours.36

  • ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C reactive protein; ESR, erythrocyte sedimentation rate; NT-ProBNP, N-terminal pro–B-type natriuretic peptide.